Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias

$896,817R44FY2019DKNIH

Crinetics Pharmaceuticals, Inc., San Diego CA

Investigators

Stephen F Betzcontact

Linked publications, trials & patents

Paper 35605837 Patent 12600709 Patent 11608335 Patent 11479540

View original record on NIH RePORTER →

Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias · GrantIndex